Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 119.23% institutional investors, 1.64% insiders. Pacer advisors is the largest institutional shareholder, holding 6.64% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.41% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical119.23%1.64%-20.88%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.23%10.67%55.10%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Pacer advisors2.14M6.64%$61.38M
Principal financial group1.65M5.10%$47.13M
Bank of new york mellon252.69K0.78%$7.24M
Assenagon asset management150.59K0.47%$4.31M
Rhumbline advisers108.23K0.34%$3.10M
Exchange traded concepts75.09K0.23%$2.15M
Los angeles capital management52.53K0.16%$1.50M
Alberta investment management40.30K0.12%$1.15M
Burney co/34.48K0.11%$987.74K
Ritholtz wealth management33.78K0.10%$967.91K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Summerhaven investment management23.91K0.42%$684.91K
Values first advisors16.91K0.27%$484.35K
Hussman strategic advisors31.50K0.27%$902.48K
Pacer advisors2.14M0.13%$61.38M
Rhs financial8.59K0.13%$246.02K
Thrive wealth management23.98K0.12%$686.91K
Exchange traded concepts75.09K0.04%$2.15M
Smith group asset management19.01K0.04%$544.69K
Meritage portfolio management20.75K0.04%$594.63K
Burney co/34.48K0.03%$987.74K

Top Buyers

HolderShares% AssetsChange
Allianz asset management gmbh21.30K0.00%14.40K
Newedge wealth12.71K0.01%12.71K
Rhumbline advisers108.23K0.00%5.92K
Harbor capital advisors27.15K0.03%3.65K
Exchange traded concepts75.09K0.04%3.40K

Top Sellers

HolderShares% AssetsChange
Pacer advisors2.14M0.13%-447.16K
Empowered funds16.57K0.01%-104.87K
Robeco institutional asset management b.v.10.24K0.00%-104.73K
Principal financial group1.65M0.03%-100.77K
Allspring global investments---79.82K

New Positions

HolderShares% AssetsChangeValue
Newedge wealth12.71K0.01%12.71K$364.06K
Spire wealth management600.000.00%600.00$17.19K
Ridgewood investments200.000.00%200.00$5.73K
Skopos labs82.000.00%82.00$2.35K
Global retirement partners55.00-55.00$1.58K

Sold Out

HolderChange
Mendota financial group-4.00
Capital performance advisors llp-22.00
Umb bank, n.a.-78.00
Eagle bay advisors-97.00
Gladius capital management lp-830.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242528.15%38,464,415-2.96%1190.79%1418.46%76-
Jun 30, 20242330.43%39,636,436-0.49%1220.81%130-76-3.80%
Mar 31, 202423218.97%39,833,4831.57%1230.84%13042.86%792.60%
Dec 31, 202319511.43%39,219,2131.31%1210.92%91-7728.33%
Sep 30, 2023175-4.37%38,712,156-1.75%1140.89%9112.35%60-14.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.07M6.41%-
Pacer US Small Cap Cash Cows 100 ETF2.02M6.26%-9.34K
Eventide Gilead N1.34M4.17%-
FullerThaler Behavioral Small-Cap Equity1.31M4.05%170.40K
FullerThaler Behavioral Sm-Cp Eq R61.31M4.05%170.40K
Eventide Healthcare & Life Sciences I1.29M3.99%-
Vanguard Total Stock Mkt Idx Inv979.17K3.04%-
iShares Russell 2000 ETF856.39K2.66%-130.00
Principal SmallCap R5586.70K1.82%-11.90K
Principal U.S. Small Cap Equity581.90K1.80%-4.40K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 10, 2025Kuhlmann Shirley R. EVP and General CounselSell$205.22K
Jan 10, 2025Kuhlmann Shirley R. EVP and General CounselSell$703.41K
Sep 13, 2024Smith Thomas B EVP and Chief Medical OfficerSell$351.32K
Sep 05, 2024Kuhlmann Shirley R. EVP and General CounselSell$93.94K
Sep 06, 2024Kuhlmann Shirley R. EVP and General CounselSell$36.59K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3-4
2024 Q2-6
2024 Q1-4
2023 Q4-5

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 119.23%, followed by 1.64% insiders and -20.87% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.23%, which Collegium Pharmaceutical exceeds.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Pacer advisors (2.14M shares, 6.64%), Principal financial group (1.65M shares, 5.10%), and Bank of new york mellon (252.69K shares, 0.78%). Together, they hold 12.52% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Summerhaven investment management is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 0.42% of its assets in 23.91K Collegium Pharmaceutical shares, valued at 684.91K$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 6.41% of its total shares outstanding invested in 2.07M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools